Nihon Chouzai Co (TSE:3341) EBIT: 円2,239 Mil (TTM As of Sep. 2025)


TSE:3341 Nihon Chouzai Co Ltd TSE:3341
51 GF Score
Price 円3,925.00
GF Value 円1,563.20
! 10 Warning Signs
View Full Analysis

What is Nihon Chouzai Co EBIT?

Nihon Chouzai Co TSE:3341 -0.13% 51 EBIT is 円2,239 Mil as of Sep. 2025. GuruFocus rates TSE:3341 with a GF Score™ of 51/100 and a GF Value™ of 円1,563.20. The stock has 10 warning signs investors should review.

Nihon Chouzai Co's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2025 was 円659 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2025 was 円2,239 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nihon Chouzai Co's annualized ROC % for the quarter that ended in Sep. 2025 was 6.29%. Nihon Chouzai Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was 3.75%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nihon Chouzai Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was 1.42%.


Nihon Chouzai Co  (TSE:3341) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nihon Chouzai Co's annualized ROC % for the quarter that ended in Sep. 2025 is calculated as:

ROC % (Q: Sep. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Sep. 2025 ))/ count )
=10276 * ( 1 - 23.5% )/( (124432 + 125336)/ 2 )
=7861.14/124884
=6.29 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Nihon Chouzai Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Sep. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2636/( ( (64911 + max(-11231, 0)) + (64794 + max(10830, 0)) )/ 2 )
=2636/( ( 64911 + 75624 )/ 2 )
=2636/70267.5
=3.75 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(23717 + 47626 + 5372) - (70605 + 0 + 17341)
=-11231

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(40974 + 48644 + 4339) - (68456 + 0 + 14671)
=10830

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nihon Chouzai Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2025 )
=2239/157805.000
=1.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nihon Chouzai Co EBIT Related Terms


Nihon Chouzai Co EBIT Historical Data

* Premium members only.

The historical data trend for Nihon Chouzai Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nihon Chouzai Co EBIT Chart

Nihon Chouzai Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,797.00 6,512.00 8,109.00 5,492.00 3,310.00

Nihon Chouzai Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 193.00 781.00 0.00 1,580.00 659.00

Nihon Chouzai Co EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Nihon Chouzai Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nihon Chouzai Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nihon Chouzai Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nihon Chouzai Co's EV-to-EBIT falls into.


TSE:3341
51GF Score
Nihon Chouzai Co Ltd TSE:3341
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nihon Chouzai Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,239 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円2,239 Mil mean?
Nihon Chouzai Co (TSE:3341) has a EBIT of 円2,239 Mil as of Sep. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nihon Chouzai Co.
Is Nihon Chouzai Co's EBIT too high?
Nihon Chouzai Co's current EBIT is 円2,239 Mil. Overall, Nihon Chouzai Co has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Nihon Chouzai Co's EBIT compare to competitors?
Nihon Chouzai Co's EBIT of 円2,239 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nihon Chouzai Co. Nihon Chouzai Co's current EBIT is 円2,239 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Chouzai Co stock overvalued right now?
Nihon Chouzai Co (TSE:3341) has a current EBIT of 円2,239 Mil. The stock's GF Value™ is 円1,563.20, compared to a current price of 円3,925.00 — trading 151.1% above its estimated fair value. The current EBIT is 円2,239 Mil. Nihon Chouzai Co's overall GF Score™ is 51/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nihon Chouzai Co (TSE:3341), the current EBIT is 円2,239 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nihon Chouzai Co (TSE:3341) Overvalued in 2026?

Based on GuruFocus' analysis, Nihon Chouzai Co stock appears to be overvalued. The current stock price of 円3,925.00 is trading 151.1% above its estimated GF Value™ of 円1,563.20.

Key valuation signals for TSE:3341:

  • EBIT: 円2,239 Mil
  • GF Value™: 円1,563.20 vs. price of 円3,925.00 (151.1% above fair value)
  • GF Score™: 51/100 with 10 warning signs

No single metric tells the full story. See the TSE:3341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nihon Chouzai Co Business Description

Address Sapporo Odori Nishi Front Park 8 floors 7-1, Tokyo, JPN
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.
51GF Score

Get the complete analysis for TSE:3341

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,925.00
Price
円1,563.20
GF Value